Both the polycythemia- and anemia-inducing strains of Friend spleen focus-forming virus induce constitutive activation of the Raf-1/mitogen- activated protein kinase signal transduction pathway

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 919-925

  Muszynski, Karen W ^a   Ohashi, Takashi ^b,c   Hanson, Charlotte ^a   Ruscetti, Sandra K ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Tokyo Medical and Dental University ^*  (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; RAF PROTEIN;

ANEMIA; ANIMAL CELL; ARTICLE; ENZYME ACTIVATION; ERYTHROPOIESIS; MOUSE; NONHUMAN; POLYCYTHEMIA; PRIORITY JOURNAL; RETROVIRUS; SIGNAL TRANSDUCTION; SPLEEN;

EID: 0031907558     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.919-925.1998     Document Type: Article

References (71)

1. Alessi, D. R., P. Cohen, A. Ashworth, S. Cowley, S. J. Leevers, and C. J. Marshall. 1995. Assay and expression of mitogen-activated protein kinase, MAP kinase kinase, and Raf. Methods Enzymol. 255:279-290.
2. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
3. Barber, D. L., J. C. DeMartino, M. O. Showers, and A. D. D'Andrea. 1994. A dominant negative erythropoietin (EPO) receptor inhibits EPO-dependent growth and blocks F-gp55-dependent transformation. Mol. Cell. Biol. 14:2257-2265.
4. Barber, D. L., C. N. Corless, K. Xia, T. M. Roberts, and A. D. D'Andrea. 1997. Erythropoietin activates Raf1 by an Shc-independent pathway in CTLL-EPO-R cells. Blood 89:55-64.
5. Blumer, K. J., and G. L. Johnson. 1994. Diversity in function and regulation of MAP kinase pathways. Trends Biochem. Sci. 19:236-240.
6. Bondurant, M. C., T. Yamashita, K. Muta, S. B. Krantz, and M. J. Koury. 1996. c-myc expression affects proliferation hut not terminal differentiation or survival of explanted erythroid progenitor cells. J. Cell. Physiol. 168:255-263.
7. Cano, E., and L. C. Mahadevan. 1995. Parallel signal processing among mammalian MAPKs. Trends Biochem. Sci. 20:117-122.
8. Carroll, M. P., J. L. Spivak, M. McMahon, N. Weich, U. R. Rapp, and W. S. May. 1991. Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation. J. Biol. Chem. 266:14964-14969.
9. Casadevall, N., C. Lacombe, O. Muller, S. Gisselbrecht, and P. Mayeux. 1991. Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemia cells (Friend cells). Cross-linking of erythropoietin with the spleen focus-forming virus envelope protein. J. Biol. Chem. 266: 16015-16020.
10. Crews, C. M., and R. L. Erikson. 1992. Purification of a murine protein-tyrosine/threonine kinase that phosphorylates and activates the Erk-1 gene product: relationship to the fission yeast byr1 gene product. Proc. Natl. Acad. Sci. USA 89:8205-8209.
11. Damen, J. E., L. Liu, R. L. Cutler, and G. Krystal. 1993. Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood 82:2296-2303.
12. D'Andrea, D. A., A. Yoshimura, H. Youssoufian, L. I. Zon, J. W. Koo, and H. F. Lodish. 1991. The cytoplasmic region of the erythropoietin receptor contains nonoverlapping positive and negative growth-regulatory domains. Mol. Cell. Biol. 11:1980-1987.
13. Darnell, J. E., Jr., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
14. Daum, G., I. Eisenmann-Tappe, H. W. Fries, J. Troppmair, and U. R. Rapp. 1994. The ins and outs of Raf kinases. Trends Biochem. Sci. 19:474-480.
15. Davis, R. J. 1995. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev. 42:459-467.
16. Dent, P., W. Haser, T. A. Haystead, L. A. Vincent, T. M. Roberts, and T. W. Sturgill. 1992. Activation of mitogen-activated protein kinase kinase by v-Raf in NIH 3T3 cells and in vitro. Science 257:1404-1407.
17. Egan, S. E., B. W. Giddings, M. W. Brooks, L. Buday, A. M. Sizeland, and R. A. Weinberg. 1993. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 363:45-51.
18. Foltz, I. N., and J. W. Schrader. 1997. Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4. Blood 89:3092-3096.
19. Franklin, C. C., and A. S. Kraft. 1995. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells. Oncogene 11:2365-2374.
20. Gille, H., A. D. Sharrocks, and P. E. Shaw. 1992. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358:414-417.
21. 2-terminal activation domain of c-Myc. FEBS Lett. 353:281-285.
22. Hankins, W. D. 1983. Increased erythropoietin sensitivity after in vitro transformation of hematopoietic precursors by RNA tumor viruses. J. Natl. Cancer Inst. 70:725-734.
23. He, T.-C., N. Jiang, H. Zhuang, and D. M. Wojchowski. 1995. Erythropoietin-induced recruitment of Shc via a receptor phosphotyrosine-independent, Jak2-associated pathway. J. Biol. Chem. 270:11055-11061.
24. Hipskind, R. A., M. Baccarini, and A. Nordheim. 1994. Transient activation of RAF-1, MEK, and ERK2 coincides kinetically with ternary complex factor phosphorylation and immediate-early gene promoter activity in vivo. Mol. Cell. Biol. 14:6219-6231.
25. r resistance gene. Proc. Natl. Acad. Sci. USA 87:9985-9989.
26. Horoszewicz, J. S., S. S. Leong, and W. A. Carter. 1975. Friend leukemia: rapid development of erythropoietin-independent hematopoietic precursors. J. Natl. Cancer Inst. 54:265-267.
27. Ihle, J. N., B. A. Witthuhn, F. W. Quelle, O. Silvennoinen, B. Tang, and T. Yi. 1994. Protein tyrosine phosphorylation in the regulation of hematopoiesis by receptors of the cytokine-receptor superfamily. Blood Cells 20:65-80.
28. Karin, M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:16483-16486.
29. Kishi, A., T. Chiba, M. Sugiyama, M. Machide, Y. Nagata, H. Amanuma, H. Taira, T. Katsumata, and K. Todokoro. 1993. Erythropoietin receptor binds to Friend virus gp55 through other membrane components. Biochem. Biophys. Res. Commun. 192:1131-1138.
30. Klinken, S. P., U. R. Rapp, and H. C. Morse III. 1989. raf/myc-infected erythroid cells are restricted in their ability to terminally differentiate. J. Virol. 63:1489-1492.
31. Koury, M. J., M. C. Bondurant, D. T. Duncan, S. B. Krantz, and W. D. Hankins. 1982. Specific differentiation events induced by erythropoietin in cells infected in vitro with the anemia strain of Friend virus. Proc. Natl. Acad. Sci. USA 79:635-639.
32. Kyriakis, J. M., H. App, X. F. Zhang, P. Banerjee, D. L. Brautigan, U. R. Rapp, and J. Avruch. 1992. Raf-1 activates MAP kinase-kinase. Nature 358:417-421.
33. Li, J. P., D. A. AD, H. F. Lodish, and D. Baltimore. 1990. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343:762-764.
34. Li, N., A. Batzer, R. Daly, V. Yajnik, E. Skolnik, P. Chardin, D. Bar-Sagi, B. Margolis, and J. Schlessinger. 1993. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signaling. Nature 363:85-88.
35. Liao, S. K., and A. A. Axelrad. 1975. Erythropoietin-independent erythroid colony formation in vitro by hemopoietic cells of mice infected with Friend virus. Int. J. Cancer 15:467-482.
36. Minden, A., A. Lin, M. McMahon, C. Lange-Carter, B. Derijard, R. J. Davis, G. L. Johnson, and M. Karin. 1994. Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719-1723.
37. Mirand, E. A. 1967. Virus-induced erythropoiesis in hypertransfused-polycythemic mice. Science 156:832-833.
38. Mirand, E. A., R. A. Steeves, R. D. Lange, and J. T. Grace Jr. 1968. Virus-induced polycythemia in mice: erythropoiesis without erythropoietin. Proc. Soc. Exp. Biol. Med. 128:844-849.
39. Miura, O., N. Nakamura, F. W. Quelle, B. A. Witthuhn, J. N. Ihle, and N. Aoki. 1994. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Blood 84:1501-1507.
40. Miura, Y., O. Miura, J. N. Ihle, and N. Aoki. 1994. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor. J. Biol. Chem. 269:29962-29969.
41. Morrison, D. K., D. R. Kaplan, U. Rapp, and T. M. Roberts. 1988. Signal transduction from membrane to cytoplasm: growth factors and membrane-bound oncogene products increase Raf-1 phosphorylation and associated protein kinase activity. Proc. Natl. Acad. Sci. USA 85:8855-8859.
42. Muszynski, K. W., F. W. Ruscetti, J. M. Gooya, D. M. Linnekin, and J. R. Keller. 1997. Raf-1 protein is required for growth factor-induced proliferation of primitive hematopoietic progenitors stimulated with synergistic combinations of cytokines. Stem Cells 15:63-72.
43. Muszynski, K. W., F. W. Ruscetti, G. Heidecker, U. Rapp, J. Troppmair, J. M. Gooya, and J. R. Keller. 1995. Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells. J. Exp. Med. 181:2189-2199.
44. Nagata, Y., E. Nishida, and K. Todokoro. 1997. Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3. Blood 89: 2664-2669.
45. Nakabeppu, Y., K. Ryder, and D. Nathans. 1988. DNA binding activities of three murine Jun proteins: stimulation by Fos. Cell 55:907-915.
46. Ohashi, T., M. Masuda, and S. K. Ruscetti. 1995. Induction of sequence-specific DNA-binding factors by erythropoietin and the spleen focus-forming virus. Blood 85:1454-1462.
47. Ohashi, T., et al. Unpublished data.
48. Patel, H. R., and A. J. Sytkowski. 1995. Erythropoietin activation of AP1 (Fos/Jun). Exp. Hematol. 23:619-625.
49. Pulverer, B. J., J. M. Kyriakis, J. Avruch, E. Nikolakaki, and J. R. Woodgett. 1991. Phosphorylation of c-jun mediated by MAP kinases. Nature 353:670-674.
50. Rapp, U. R. 1991. Role of Raf-1 serine/threonine protein kinase in growth factor signal transduction. Oncogene 6:495-500.
51. Ruscetti, S., and L. Wolff. 1985. Biological and biochemical differences between variants of spleen focus-forming virus can be localized to a region containing the 3′ end of the envelope gene. J. Virol. 56:717-722.
52. 3H]thymidine-incorporation assay to distinguish the effects of different Friend erythroleukemia-inducing retroviruses on erythroid cell proliferation. J. Natl. Cancer Inst. 77:241-245.
53. Ruscetti, S. K. 1995. Erythroleukaemia induction by the Friend spleen focus-forming virus. Baillieres Clin. Haematol. 8:225-247.
54. Ruscetti, S. K., N. J. Janesch, A. Chakraborti, S. T. Sawyer, and W. D. Hankins. 1990. Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line. J. Virol. 64:1057-1062.
55. Sassa, S., F. Takaku, and K. Nakao. 1968. Regulation of erythropoiesis in the Friend leukemia mouse. Blood 31:758-765.
56. Sassone-Corsi, P., L. J. Ransone, W. W. Lamph, and I. M. Verma. 1988. Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain. Nature 336:692-695.
57. 2-terminal domain of c-Myc increases transactivation of gene expression. J. Biol. Chem. 266:23521-23524.
58. Silvennoinen, O., J. N. Ihle, J. Schlessinger, and D. E. Levy. 1993. Interferon-induced nuclear signaling by Jak protein tyrosine kinases. Nature 366: 583-585.
59. Simon, M. A., G. S. Dodson, and G. M. Rubin. 1993. An SH3-SH2-SH3 protein is required for p21 Ras1 activation and binds to sevenless and Sos proteins in vitro. Cell 73:169-177.
60. Spangler, R., S. C. Bailey, and A. J. Sytkowski. 1991. Erythropoietin increases c-myc mRNA by a protein kinase C-dependent pathway. J. Biol. Chem. 266:681-684.
61. Spivak, J. L., T. Pham, M. Isaacs, and W. D. Hankins. 1991. Erythropoietin is both a mitogen and a survival factor. Blood 77:1228-1233.
62. Steinheider, G., H. J. Seidel, and L. Kreja. 1979. Comparison of the biological effects of anemia inducing and polycythemia inducing Friend virus complex. Experientia 35:1173-1175.
63. Stokoe, D., S. G. Macdonald, K. Cadwallader, M. Symons, and J. F. Hancock. 1994. Activation of Raf as a result of recruitment to the plasma membrane. Science 264:1463-1467.
64. Su, B., and M. Karin. 1996. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr. Opin. Immunol. 8:402-411.
65. Tambourin, P., and F. Wendling. 1971. Malignant transformation and erythroid differentiation by polycythaemia-inducing Friend virus. Nature New Biol. 234:230-233.
66. Tambourin, P. E., F. Wendling, C. Jasmin, and F. Smadja-Joffe. 1979. The physiopathology of Friend leukemia. Leuk. Res. 3:117-129.
67. Tsuda, H., N. Aso, T. Sawada, H. Hata, M. Kawakita, K. J. Mori, and K. Takatsuki. 1991. Alteration of nuclear proto-oncogene expression by erythropoietin (Epo) in Epo-responsive murine cell lines. Int. J. Cell Cloning 9:123-133.
68. Wolff, L., and S. Ruscetti. 1985. Malignant transformation of erythroid cells in vivo by introduction of a nonreplicating retrovirus vector. Science 228: 1549-1552.
69. Wolff, L., and S. Ruscetti. 1988. The spleen focus-forming virus (SFFV) envelope gene, when introduced into mice in the absence of other SFFV genes, induces acute erythroleukemia. J. Virol. 62:2158-163.
70. Yoshimura, A., G. Longmore, and H. F. Lodish. 1990. Point mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicity. Nature 348:647-649.
71. Yoshimura, A., T. Zimmers, D. Neumann, G. Longmore, Y. Yoshimura, and H. F. Lodish. 1992. Mutations in the Trp-Ser-X-Trp-Ser motif of the erythropoietin receptor abolish processing, ligand binding, and activation of the receptor. J. Biol. Chem. 267:11619-11625.